Undiscovered Stocks
Long/short equity

Mesa Laboratories: A Highly Overvalued Levered Rollup With Low Single-Digit Organic Growth And Aggressive Insider Selling

On the surface, Mesa Laboratories (NASDAQ:MLAB) looks interesting. This is a company with 60% gross margins and 20% operating margins in an attractive industry. However, when I take a closer look at the business, I realize that all the growth is generated by acquisitions and that the company is only growing 2% organically. Hence, investors are paying 5 times sales for a rollup with almost zero organic growth. Furthermore, not only is the stock highly illiquid, but insiders have been quietly, but aggressively, selling their shares. The company also continues to lever up the balance sheet while trying to convince shareholders that they will be able to create synergies from all the acquisitions they have made (four in...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details